Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-24 @ 7:24 PM
NCT ID:
NCT04365803
Eligibility Criteria:
Inclusion Criteria:
* age ≥ 18 aa;
* histological diagnosis done at European Institute of Oncology (if not, to does revision of pathological material);
* invasive ductal breast cancer triple negative or HER2 overexpressed, any cN;
* neoadjuvant standard systemic treatment after surgery +/- trastuzumab;
* propose of conservative or demolitive surgery;
* M0
* cancer bed identified pre neoadjuvant chemotherapy by clip
Exclusion Criteria:
* multicentric or bilateral breast cancer
* mammography microcalcifications
* in situ breast carcinoma
* positive anamnesis for previous breast cancer
* positive anamnesis for medical or psychological conditions that prevent membership study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04365803
Study Brief:
Protocol Section:
NCT04365803